5Muller R H, Mader K, Gohla S. Solid lipid nanoparticles (SLN)for controlled drug delivery- A review of the state of the art[ J]. Eur J Pharrn Biopharrn, 2000,50 ( 1 ) : 161 - 177.
6Shuyu Xie, SiLiang Wang, BaoKai Zhao, et al. Effect of PLGA as a polymeric emulsifer on preparation of hydrophilic proteinloaded solid lipid nanoparticles [ J ]. Colloids and Surfaces B: Biointerfaces, 2008,67 : 199 - 204.
7Shuyu Xie, Luyan Zhu, Zhao Dong, et al. Preparation, characterization and pharmacokinetics of enrofloxacin - loaded solid lipid nanoparticles : Influences of fatty acids [ J ]. Colloids and Surfaces B : Biointerfaees .2011.83:382 - 387.
8Nielsen P, Gyrd - hansen N. Bioavailability of enrofloxacin after oral administration to fed and fasted pigs [ J ]. Pharmaeology & Toxieology, 1997,80:246 - 250.
9Vaneutsem P M, Babish J G, Sehwark W S. The fluomquinolone antimicrobials: Structure, antimicrobial activity, phannacokinetics, clinical use in domestic animals and toxicity [ J ]. Cornell Veterinary, 1990,80 : 86 - 173.
